Overview
- 54 inspections across 46 sites are on record.
- 173 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-05-03.
At a glance
Inspections
54
Sites
46
Observations
173
Career since
Jun 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Simtra Deutschland GmbH | 3 May 2023 | Human Drugs | |
| Curia New Mexico, LLC | 17 Feb 2023 | Human Drugs | |
| SOCIETAL CDMO SAN DIEGO, LLC | 25 Jan 2023 | Human Drugs | View 483 → |
| Hyland's Consumer Health Inc. | 29 Nov 2022 | Human Drugs | View 483 → |
| Daito Pharmaceutical Co., Ltd | 16 Sep 2022 | Human Drugs | On file |
Sites inspected
Simtra Deutschland GmbHHalle (Westf.), Germany1 insp.
Curia New Mexico, LLCAlbuquerque, United States1 insp.
SOCIETAL CDMO SAN DIEGO, LLCSan Diego, United States1 insp.
Hyland's Consumer Health Inc.Los Angeles, United States1 insp.
Daito Pharmaceutical Co., LtdToyama, Japan1 insp.
Co-investigators
Investigators who share inspections with this person.
Nicholas L Hunt5 shared
Joey V Quitania3 shared
Walden H Lee2 shared
Amir Alavi2 shared
Zachery L Miller2 shared
Christopher M Jenner2 shared
Theresa Kirkham2 shared
Rachel C Stanton1 shared
Michael Araneta1 shared
James B Arnett1 shared
Full investigator report
Get the verbatim findings behind Santiago Gallardo Johnson's 173 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site